Record title

A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer

Record identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d90b26c5c0984e26bded0075c4324f98

https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d90b26c5c0984e26bded0075c4324f98

A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer

About this item

Full title

A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer

Publisher

England: BioMed Central Ltd

Journal title

Biomarker research, 2021, Vol.9 (1), p.24-9

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d90b26c5c0984e26bded0075c4324f98

Language

English

Formats

Publication information

Publisher

More information

Scope and Contents

Contents

Alternative Titles

Full title

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d90b26c5c0984e26bded0075c4324f98

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d90b26c5c0984e26bded0075c4324f98

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item